Prosecution Insights
Last updated: April 19, 2026

Examiner: BEHARRY, ZANNA MARIA

Tech Center 1600 • Art Units: 1632

This examiner grants 22% of resolved cases

Performance Statistics

22.4%
Allow Rate
-37.6% vs TC avg
138
Total Applications
+51.5%
Interview Lift
1434
Avg Prosecution Days
Based on 58 resolved cases, 2023–2026

Rejection Statute Breakdown

5.9%
§101 Eligibility
15.9%
§102 Novelty
42.2%
§103 Obviousness
26.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17598963 METHODS TO ENHANCE T CELL REGENERATION Final Rejection President and Fellows of Harvard College
17615579 REPRODUCIBLE BRAIN ORGANOIDS AND METHODS OF MAKING Non-Final OA The Broad Institute, Inc.
17433874 METHOD FOR PRODUCING CELL SPHEROIDS Non-Final OA NIPPON SHOKUBAI CO., LTD.
18029026 PARATHYROID GLAND CELLS Non-Final OA Takeda Pharmaceutical Company Limited
17286534 Soluble Extracellular Matrix Composition and Method for Intravascular Delivery Non-Final OA The Regents of the University of California
18319265 METHODS AND ASSAYS FOR ANALYZING SECRETOME-CONTAINING COMPOSITIONS Final Rejection FUJIFILM Corporation
17925355 COMPOSITION FOR ENHANCING IMMUNE RESPONSE BY USING ACTIVATION FUNCTION OF DENDRITIC CELLS OF STROMAL VASCULAR FRACTIONS ISOLATED FROM ADIPOSE TISSUES Final Rejection KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION
18016266 METHOD FOR PRODUCING CARDIOMYOCYTE SPHEROIDS Non-Final OA KANEKA CORPORATION
17927816 METHOD OF PRODUCING ORGANOID DERIVED FROM LUNG EPITHELIAL CELL OR LUNG CANCER CELL Non-Final OA RIKEN
17617191 RED BLOOD CELL STORAGE SOLUTIONS, ADDITIVES, AND METHODS FOR IMPROVING THE STORAGE OF RED BLOOD CELLS USING INORGANIC PYROPHOSPHATES Non-Final OA University of Cincinnati
18286205 COMPOSITIONS AND METHODS FOR TREATMENT OF CRX-MEDIATED RETINOPATHIES Non-Final OA Washington University
17843086 PERFUSION SYSTEM FOR CORNEAL ENDOTHELIAL CELL GRAFT EVALUATION Final Rejection REGENTS OF THE UNIVERSITY OF MINNESOTA
17626728 ZEBRAFISH DELETION AND COMPOUND MUTANTS AND USES THEREOF Non-Final OA The General Hospital Corporation
17428593 PRESERVATION OF VASCULARIZED COMPOSITE ALLOGRAFTS Final Rejection The General Hospital Corporation
17917992 NON-HUMAN ANIMAL SECRETOME MODELS Non-Final OA University of Pittsburgh - Of the Commonwealth System of Higher Education
17756398 THYMUS ORGANOIDS BIOENGINEERED FROM HUMAN PLURIPOTENT STEM CELLS Non-Final OA University of Pittsburgh - of the Commonwealth System of Higher Education
17492137 METHODS OF PROMOTING THYMIC EPITHELIAL CELL AND THYMIC EPITHELIAL CELL PROGENITOR DIFFERENTIATION OF PLURIPOTENT STEM CELLS, RESULTING CELLS, AND USES THEREOF Final Rejection THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
17204147 Hybrid Thymus, Methods of Making, and Methods of Using to Induce Xenograft Tolerance, Restore Immunocompetence and Thymic Function Final Rejection THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
18924564 SCALABLE FABRICATION OF A SELF-ASSEMBLED CELL SHEET AND USES THEREOF Final Rejection McMaster University
17773784 BRAIN ORGANOID AND USE THEREOF Non-Final OA KEIO UNIVERSITY
17054097 Combined Purification and Concentration by Deterministic Lateral Displacement With Recirculation of Product Non-Final OA ZEON CORPORATION
18476573 COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING ALTERNATING ELECTRIC FIELDS AND APOPTOTIC CANCER CELL VACCINATION Non-Final OA Novocure GmbH
17856653 STEM CELL FATE ENGINEERING METHODS Final Rejection Wisconsin Alumni Research Foundation
18248739 METHODS FOR MAKING AND USING DIFFERENTIATED NEURAL CELLS Non-Final OA Research Development Foundation
17257719 Dispersion of Pluripotent Stem Cells, and Pluripotent Stem Cell Product and Method for Producing Same Non-Final OA RACTHERA Co., Ltd.
17458558 CELL CULTURE AUXILIARY AGENT AND CELL CULTURE MEDIUM USING THE SAME Final Rejection 3D GLOBAL BIOTECH INC.
18562797 EX VIVO HUMAN MODEL INTENDED FOR EVALUATING ALLERGIC OR PSEUDO-ALLERGIC INFLAMMATORY POTENTIAL Final Rejection GENOSKIN
17915729 METHODS OF MAKING PLURIPOTENT STEM CELLS AND USES THEREOF Non-Final OA NATIONAL JEWISH HEALTH
18262894 BACTERIA PRODUCING GAMMA-AMINOBUTYRIC ACID (GABA) AND USES OF THE BACTERIA Non-Final OA Eastern Washington University
18253047 PANCREAS EXTRACELLULAR MATRIX DERIVED SCAFFOLD FOR CULTURE AND TRANSPLANTATION OF PANCREATIC ORGANOID AND METHOD OF PREPARING THE SAME Non-Final OA CELLARTGEN INC.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month